First New ADHD Treatment in 30 Years.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      UNITED States
    • Subject Terms:
      UNITED States. Food & Drug Administration
    • Abstract:
      Reports on the decision of the U.S. Food and Drug Administration to approve the use of atomoxetine in the treatment of attention deficit hyperactivity disorder (ADHD) in November 2002. Symptoms of ADHD; Traditional treatment modalities for ADHD; Results of clinical trials of atomoxetine.